Backed by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugs

Basecamp Research receives $140M to advance AI-designed drugs.

Basecamp Research has received $140M in funding from investors including NVIDIA and Anthropic to advance AI-designed drugs.

This investment is part of a growing trend of AI-forward biotechs securing notable funding in recent months.

Basecamp Research joins companies like Isomorphic Labs and Enveda in this category.